slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6.570 KRW | -0,61% | +1,08% | -8,50% |
2023 | Korean Drug Co. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
Omzet 2022 | 79,98 mld. 58,07 mln. 54,55 mln. | Omzet 2023 | 81,37 mld. 59,08 mln. 55,5 mln. | Marktkapitalisatie | 78,35 mld. 56,88 mln. 53,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 11,81 mld. 8,57 mln. 8,05 mln. | Nettowinst (verlies) 2023 | -4,92 mld. -3,57 mln. -3,35 mln. | EV/omzet 2022 | 0,74 x |
Nettoliquiditeiten 2022 | 26,34 mld. 19,12 mln. 17,96 mln. | Nettoliquiditeiten 2023 | 16,69 mld. 12,12 mln. 11,38 mln. | EV/omzet 2023 | 0,76 x |
K/w-verhouding 2022 |
7,15
x | K/w-verhouding 2023 |
-15,7
x | Werknemers | 270 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 47,87% |
1 dag | -0,61% | ||
1 week | +1,08% | ||
Lopende maand | -2,81% | ||
1 maand | -0,45% | ||
3 maanden | -2,67% | ||
6 maanden | -3,38% | ||
Lopend jaar | -8,50% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sang-Hoon Park
CEO | Chief Executive Officer | 57 | - |
Hae-Ryong Park
CEO | Chief Executive Officer | 88 | - |
Kyung-Deuk Lee
BRD | Director/Board Member | 62 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hae-Ryong Park
CEO | Chief Executive Officer | 88 | - |
Sang-Hoon Park
CEO | Chief Executive Officer | 57 | - |
Kyung-Deuk Lee
BRD | Director/Board Member | 62 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 6.570 | -0,61% | 11 330 |
18-04-24 | 6.610 | +1,23% | 12 526 |
17-04-24 | 6.530 | +0,62% | 15 369 |
16-04-24 | 6.490 | -1,67% | 35 709 |
15-04-24 | 6.600 | -1,49% | 15 186 |
slotkoers Korea S.E., 19 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-8,50% | 52,4 mln. | |
+20,91% | 43,54 mld. | |
+16,96% | 21,74 mld. | |
+9,05% | 13,53 mld. | |
+7,98% | 13,02 mld. | |
+33,80% | 11,28 mld. | |
-11,05% | 6,99 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+7,71% | 5,09 mld. |